ROYAL BANK OF CANADA - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 36 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q4 2020$1,478,000
+245.3%
1,485,000
+236.7%
0.00%
Q3 2020$428,000
+3466.7%
441,000
+3292.3%
0.00%
Q3 2019$12,000
-99.7%
13,000
-99.6%
0.00%
-100.0%
Q2 2017$3,742,000
+0.8%
3,478,000
+0.2%
0.00%0.0%
Q1 2017$3,712,000
+11.2%
3,471,000
+14.0%
0.00%0.0%
Q4 2016$3,338,000
+66.0%
3,046,000
+80.7%
0.00%
+100.0%
Q3 2016$2,011,000
-22.5%
1,686,000
-18.4%
0.00%
-50.0%
Q2 2016$2,594,000
-18.2%
2,065,000
-4.6%
0.00%0.0%
Q1 2016$3,172,000
+5.0%
2,165,000
+12.5%
0.00%0.0%
Q4 2015$3,022,000
+9.8%
1,925,000
-4.9%
0.00%0.0%
Q3 2015$2,752,000
+49.7%
2,025,000
+52.7%
0.00%
+100.0%
Q2 2015$1,838,000
+135.9%
1,326,000
+152.6%
0.00%0.0%
Q1 2015$779,000
+63.0%
525,000
+50.0%
0.00%
Q4 2014$478,000
+7.9%
350,000
+1.4%
0.00%
Q3 2014$443,000
+73.0%
345,000
+72.5%
0.00%
Q2 2014$256,000
+3.6%
200,000
+2.6%
0.00%
Q1 2014$247,000
+29.3%
195,000
+8.3%
0.00%
Q4 2013$191,000
+2.1%
180,0000.0%0.00%
Q3 2013$187,000
-7.4%
180,000
-6.2%
0.00%
Q2 2013$202,000192,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q2 2013
NameSharesValueWeighting ↓
Southpaw Asset Management LP 20,000,000$17,675,00025.38%
INCOME RESEARCH & MANAGEMENT 23,109,000$20,278,0005.29%
Fore Capital, LLC 5,000,000$4,430,0001.71%
RIVERHEAD CAPITAL MANAGEMENT LLC 20,000,000$17,603,0000.74%
ARISTEIA CAPITAL, L.L.C. 18,500,000$16,361,0000.70%
ZAZOVE ASSOCIATES LLC 11,153,000$9,843,0000.58%
BASSO CAPITAL MANAGEMENT, L.P. 3,600,000$3,182,0000.52%
CSS LLC/IL 10,450,000$9,240,0000.45%
Lombard Odier Asset Management (Europe) Ltd 7,950,000$7,038,0000.44%
Wellesley Asset Management 6,740$5,948,0000.31%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders